Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

140.20
Delayed Data
As of Oct 17
 -3.10 / -2.16%
Today’s Change
37.05
Today|||52-Week Range
145.40
+127.23%
Year-to-Date
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close143.30
Today’s open144.00
Day’s range138.75 - 145.40
Volume669,683
Average volume (3 months)945,684
Market cap$6.5B
Dividend yield--
Data as of 10/17/2017

Growth & Valuation

Earnings growth (last year)-46.99%
Earnings growth (this year)+3.01%
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)-56.28%
P/E ratioNM
Price/Sales373.75
Price/Book6.71

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc+0.91+1.54%
NBIXNeurocrine Bioscienc...-0.27-0.44%
EXASExact Sciences Corp-0.71-1.50%
TECHBio-Techne Corp+0.80+0.65%
Data as of 10/17/2017

Financials

Next reporting dateNovember 16, 2017
EPS forecast (this quarter)-$1.71
Annual revenue (last year)$6.2M
Annual profit (last year)-$263.5M
Net profit margin-4,281.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts